Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases
15 11월 2024 - 10:00PM
Business Wire
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in
serving science, today announced that its Board of Directors has
authorized the repurchase of $4 billion of shares of its common
stock in the open market or in negotiated transactions. The
authorization has no expiration date. This replaces the company’s
existing repurchase authorization, of which $1 billion was
remaining.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue of approximately $40 billion. Our
Mission is to enable our customers to make the world healthier,
cleaner and safer. Whether our customers are accelerating life
sciences research, solving complex analytical challenges,
increasing productivity in their laboratories, improving patient
health through diagnostics or the development and manufacture of
life-changing therapies, we are here to support them. Our global
team delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services,
Patheon and PPD. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241115656946/en/
Media Contact Information: Sandy Pound 781-622-1223
sandy.pound@thermofisher.com
Investor Contact Information: Rafael Tejada 781-622-1356
rafael.tejada@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Thermo Fisher Scientific (NYSE:TMO)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
